Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DFTX Definium Therapeutics

Trading 09-25 13:23:50 EDT

36.69

-0.04

-0.11%

High37.00	Low36.23	Vol683.21K
Open37.00	D1 Closing36.73	Amplitude2.10%
Mkt Cap4.93B	Tradable Cap4.55B	Total Shares134.37M
T/O25.04M	T/O Rate0.55%	Tradable Shares124.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":36.69,"timestamp":1790357029130,"preClose":36.73,"halted":0,"volume":683214,"delay":0,"changeRate":-0.0010890280424720705,"floatShares":124000000,"shares":134366950,"eps":-3.482311,"marketStatus":"Trading","change":-0.04,"latestTime":"09-25 13:23:50 EDT","open":37,"high":37,"low":36.2301,"amount":25044123.310332,"amplitude":0.020961,"askPrice":36.71,"askSize":100,"bidPrice":36.66,"bidSize":242,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790366400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":36.73,"preHourTrading":{"tag":"盘前","latestPrice":37.33,"preClose":36.73,"latestTime":"09:26 EDT","volume":2667,"amount":98865.321954,"timestamp":1790342800344,"change":0.6,"changeRate":0.016335,"amplitude":0.033488},"postHourTrading":{"tag":"盘后","latestPrice":36.82,"preClose":36.73,"latestTime":"19:57 EDT","volume":53323,"amount":1958997.7514,"timestamp":1790294234034,"change":0.09,"changeRate":0.00245,"amplitude":0.029447},"volumeRatio":0.473329,"impliedVol":0.6038,"impliedVolPercentile":0.0057},"requestUrl":"/m/hq/s/DFTX/tweets","defaultTab":"tweets","newsList":[{"id":"2668905145","title":"Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668905145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668905145?lang=en_us&edition=fundamental","pubTime":"2026-09-19 22:40","pubTimestamp":1789828824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Contineum Therapeutics, Inc. Class A (CTNM) and Defi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-contineum-therapeutics-inc-class-a-ctnm-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-contineum-therapeutics-inc-class-a-ctnm-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","BK4585","CTNM","BK4588","HCSG","BK4581","LABU","DFTX","LU0029874061.USD","BK4137","BK4007","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668793185","title":"Definium Therapeutics Issues Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2668793185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668793185?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:09","pubTimestamp":1789600153,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has shared an update. Definium Therapeutics has granted stock options to three newly hired non-executive employee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-inducement-stock-options-to-new-hires-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668071939","title":"Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety","url":"https://stock-news.laohu8.com/highlight/detail?id=2668071939","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668071939?lang=en_us&edition=fundamental","pubTime":"2026-09-17 07:08","pubTimestamp":1789600138,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has shared an announcement. Definium Therapeutics reported positive topline results from its Panorama Phase 3 tri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-logs-third-positive-phase-3-readout-for-dt120-in-anxiety?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-logs-third-positive-phase-3-readout-for-dt120-in-anxiety?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667761606","title":"China's Lepu Biopharma H1 Revenue Rises 12.1% on Higher Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2667761606","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667761606?lang=en_us&edition=fundamental","pubTime":"2026-09-16 16:42","pubTimestamp":1789548131,"startTime":"0","endTime":"0","summary":"China's Lepu Biopharma H1 revenue rises 12.1% on higher drug salesOverviewChina oncology therapeutics developer's H1 2026 revenue grew 12.1% yr/yrDomestic commercialization revenue more than doubled, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL1N45807H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM643.USD","LU0997586432.USD","AZN.UK","02157","LU1983299246.USD","LU1481600234.SGD","LU0047473722.SGD","IE00BFTCPJ56.SGD","LU1355424745.HKD","LU1267930813.SGD","LU1496350502.SGD","LU2355687059.USD","LU0882574055.USD","LU0128525929.USD","LU0640478417.SGD","LU2125909247.SGD","LU1301847155.USD","LU0976567544.SGD","LU0889566641.SGD","LU2433249047.HKD","LU0972486137.USD","LU1267930573.SGD","LU1170363599.USD","IE0034235188.USD","LU0211327993.USD","DFTX","LU1003076772.USD","IE00B3T34201.USD","LU1323610961.USD","LU0920840948.USD","IE0002141913.USD","LU1119994496.HKD","BK5011","LU0784385170.HKD","LU2125909593.SGD","LU0499090636.EUR","LU0128525689.USD","IE00BJT1NW94.SGD","LU1196032939.SGD","BK1161","LU1989772923.USD","03165","LU1061106388.HKD","IE00B2B36J28.USD","LU0114720955.EUR","LU0052756011.USD","LU2089984988.USD","LU1496350171.SGD","LU1153584641.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667391679","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667391679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667391679?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:05","pubTimestamp":1789524333,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Definium Therapeutics yesterday and set a price target of $67.00. According to TipR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628789","title":"Definium Therapeutics is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628789","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628789?lang=en_us&edition=fundamental","pubTime":"2026-09-15 22:25","pubTimestamp":1789482300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667261429","title":"U.S. Research Roundup-Eli Lilly, McDonald's, Welltower","url":"https://stock-news.laohu8.com/highlight/detail?id=2667261429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667261429?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:19","pubTimestamp":1789456752,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Eli Lilly, McDonald's, WelltowerSept 15 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Eli Lilly, M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASTH","ZBRA","GLW","CAKE","SRRK","CRDF","SYK","BWIN","MIDD","DT","BSX","MCD","LIF","MSTR","LEA","USRT","LLY","RBLU","CNP","LYNX","SMST","VC","DAVE","AGL","SYM","RMD","RBLY","SPCX","WELL","NTSK","PPL","THRM","JAN","RBLX","RWR","AAON","ENVA","VTR","RIVN","HR","DOC","NKE","IBP","BKV","THO","DFTX","ULTA","VSH","PLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667619028","title":"UK's ImmuPharma Interim Net Loss Widens on Derivative Finance Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2667619028","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667619028?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:16","pubTimestamp":1789452975,"startTime":"0","endTime":"0","summary":"UK's ImmuPharma interim net loss widens on derivative finance lossOverviewUK drug developer's interim net loss widened to 4.7 mln on derivative finance lossOperating loss for the half-year narrowed sl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N457064:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK5011","BK4007","DFTX","IMM.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667619035","title":"UK's ValiRx Half-Year Loss Narrows, Cash Position Improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2667619035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667619035?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:15","pubTimestamp":1789452938,"startTime":"0","endTime":"0","summary":"UK's ValiRx half-year loss narrows, cash position improvesOverviewUK cancer therapeutics developer's half-year loss narrowed, administrative expenses reducedCompany's cash position improved after June","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N45705L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693077","title":"Kestra Medical Technologies Q1 Revenue Beats Estimates, Raises FY Revenue Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693077","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693077?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:12","pubTimestamp":1789416751,"startTime":"0","endTime":"0","summary":"Kestra Medical Technologies Q1 revenue beats estimates, raises FY revenue outlookOverviewUS wearable medical device maker's fiscal Q1 revenue grew 60%, beating analyst expectationsAdjusted EBITDA loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560UB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","DFTX","BK4007","KMTS","SRRK","THNR","BK4139","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693327","title":"Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693327?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:30","pubTimestamp":1789414223,"startTime":"0","endTime":"0","summary":"UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugsSept 14 (Reuters)-Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DFTX","PSIL","CMPS","ATAI","BK4007","BK4539","GHRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670066","title":"Definium Therapeutics price target raised to $91 from $75 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667670066?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403417,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Definium Therapeutics (DFTX) to $91 from $75 and keeps a Buy rating on the shares. Definium reported positiv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-91-from-75-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-91-from-75-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667454","title":"FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667454?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:20","pubTimestamp":1789402802,"startTime":"0","endTime":"0","summary":"FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers paceSept 14 (Reuters)-The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4531CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAI","BK4007","BK4539","CMPS","DFTX","GHRS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667409","title":"Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667409?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:10","pubTimestamp":1789402226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corbus Pharmaceuticals (CRBP) and Definium Therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","DFTX","CRBP","BK4585","HCSG","LU0128526141.USD","LABU","BK4137","BK4139","LU0029874061.USD","XLV","BK4588","BK4007","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667678916","title":"Top Midday Stories: No OpenAI IPO in 2026, Altman Reportedly Says; Nvidia, Palantir Said to Restrict AI Usage Over Customer Data Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2667678916","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667678916?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:56","pubTimestamp":1789401389,"startTime":"0","endTime":"0","summary":"All three major US stock indexes were down in late-morning trading Monday, as major artificial intelligence companies flagged concerns about the risks posed to humanity by the rapid advancement of AI ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2602419157.SGD","LU0289960550.SGD","LU1814569148.SGD","LU2247934214.USD","LU2210150020.SGD","IE00B19Z8X17.USD","LU0130102774.USD","SGXZ51526630.SGD","IE00B5949003.HKD","LU1340139317.AUD","LU0061475181.USD","LU1691799644.USD","TEK","IE00B3SWFQ91.USD","LU0225283273.USD","LU2394011477.USD","LU2506952097.USD","LU0069063385.USD","LU0124676726.USD","BK4549","LU0985489474.SGD","LU2111349929.HKD","BK4141","NVDS","LU0950375773.USD","NVII","IE000ITXATA3.USD","IE00B5TLWC47.USD","LU2168564149.EUR","IE00BDCRKT87.USD","LU0784385170.HKD","LU1815333072.USD","LU2054465674.USD","LU2065171402.SGD","IE00BHPRN162.USD","LU1923622614.USD","BK4532","LU1366333091.USD","LU2637965513.SGD","IE00BZ9MQY76.HKD","LU1496350171.SGD","LU0057025933.USD","LU0894486033.HKD","LU1127390331.HKD","LU1267930573.SGD","LU0444971666.USD","LU0960925559.SGD","LU1188199696.SGD","LU2896262040.SGD","BK4528","PLTU","IE0004445239.USD","LU2168563687.JPY","LU0094547139.USD","IE00B775SV38.USD","BK4135","MSFU","LU2360106780.USD","LU0348723411.USD","LU1668664300.SGD","LU0127658192.USD","LU2999663052.SGD","BK4007","FAI","LU1585245621.USD","SG9999001424.SGD","LU0545562505.USD","LU0545039389.USD","PLTD","LU0312595415.SGD","LU1116320901.HKD","LU0672654240.SGD","LU0265550946.USD","LU1069344957.HKD","SORCLmain","IE000WAW04H5.SGD","LU2244417387.USD","LU1934455863.HKD","ORCL","LU0820562030.AUD","IE00BQXX3C00.GBP","ROM","FDTX","LU1435385759.SGD","MSFD","LU0353189763.USD","LU1221951046.USD","LU1791710400.SGD","IE00BGHQF748.EUR","BK4097","LU0314106906.USD","BK4581","LU1119994496.HKD","LU0345769631.USD","BK4612","PSP","SGXZ80539844.SGD","LU1778281490.HKD","NVDU","SOXQ","GUNZ","NVIW.SI","LU0210528500.USD","LU1670710588.SGD","LU2552382058.USD","AON","LU2462591350.SGD","LU0979878070.USD","MSFW","LU0210533765.USD","LU2092937221.SGD","LU2430703095.HKD","LU1116320737.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU0345774631.USD","MSFX","LU1803068979.SGD","LU1804176565.USD","IE00B4JS1V06.HKD","LU0878866978.SGD","LU1989772923.USD","LU2471134796.USD","LU2322448791.USD","LU2487616109.SGD","NVDX","ORCZ","LU0289961442.SGD","LU0719512351.SGD","LU0107464264.USD","ESUM","07388","LU0786609619.USD","SGXZ99366536.SGD","LU1032955483.USD","IE00B7KXQ091.USD","BK4548","LU1316542783.SGD","LU0965509101.SGD","LU1988902786.USD","LU0868494708.USD","LU1791710582.SGD","LU2041044095.USD","IE00BYXW3230.USD","LU1066051811.HKD","LU1821325948.USD","LU2237957811.SGD","LU0266013472.USD","LU1861127337.USD","LU2089284900.SGD","LU0788109477.HKD","LU1720051108.HKD","LU2491049909.HKD","WISE","GB00B4LPDJ14.GBP","LU1267930813.SGD","LU0234572021.USD","LU0157215616.USD","LU2092627202.USD","NVDA","BK4535","AIPI","NVYY","SG9999001077.SGD","LU1992135472.HKD","BK4592","LU1032466523.USD","LU1267930730.SGD","LU2552382132.HKD","LU1244550577.SGD","LU1951198990.SGD","AGOX","NVDQ","BK4614","LU1989773731.SGD","LU1670710661.SGD","LU1880398554.USD","LU0072462426.USD","LU0985320562.USD","LU0494093205.USD","HK0000306701.USD","LU1670627923.USD","LU1043141123.HKD","IE0009G5SDU7.USD","LU2097344357.USD","SG9999014575.USD","LU0081259029.USD","BK4559","LU1037948541.HKD","LU0265550359.USD","HK0000532082.HKD","BK4538","LU2095319765.USD","LU1923622291.USD","LU1951200564.SGD","LU0323591593.USD","LU2237443549.SGD","LU2360108059.USD","ORCS","BK4504","LU2458330243.SGD","LU2242650005.HKD","LU1323610961.USD","LU1642822529.SGD","LU0823434583.USD","LU2191332357.HKD","LU1674673691.USD","IE0004445015.USD","LU2211815571.USD","IE00BZ1G4Q59.USD","LU0823421333.USD","BK4550","LU2433249047.HKD","LU1571399168.USD","SG9999000418.SGD","LU1989764664.SGD","LU0162691827.USD","LU0256863811.USD","LU2756315664.SGD","LU2860962120.EUR","BK4123","LU1699723380.USD","LU0757359368.USD","LU2106854487.HKD","LU1670628061.USD","LU1564329461.SGD","LU2452424414.USD","IE0000B7K699.USD","BK4566","LU1043141396.HKD","IE00B3QW5Z07.USD","LU0957808578.USD","BK4567","SG9999014542.SGD","METV","LU0211331839.USD","LU1084165304.USD","LU2023250843.SGD","LU2461242641.AUD","LU2125909916.SGD","LU0395794307.EUR","VT","LU0342679015.USD","LU0267386448.USD","LU1861559042.SGD","LU2473716301.USD","LU2462157665.USD","LU0742534661.SGD","LU0726765562.USD","LU0345769128.USD","LU0138981039.USD","LU1400636574.HKD","LU0823417653.USD","LU0289739343.SGD","LU0082616367.USD","LU0133085943.USD","LU2430703251.USD","LU2463028550.USD","LU1235294995.USD","LU0109392836.USD","BK4613","LU1732799900.SGD","PLTW","LU0203201768.USD","LU2063271972.USD","NVD","IE00BJTD4N35.SGD","EFIV","MSFO","LU0456855351.SGD","LU2097344431.USD","LU2125154778.USD","LU2168564222.USD","LU1236620750.USD","SGXZ23171101.USD","LU0823421416.USD","LU0302445910.USD","EYES","IE00B19Z8W00.USD","IE00BQXX3F31.USD","LU0080751232.USD","LU2413666426.HKD","THMR","IE00BLSP4239.USD","LU2272731865.HKD","PLTA","LU0154236417.USD","ORCX","SPLTRmain","LU1236620834.HKD","LU1548497426.USD","SOXY","LU0029864427.USD","LU2237438978.USD","LU2065171311.SGD","TTEQ","BK4533","LU1201861249.SGD","ESLG","LU0949170426.SGD","BK4173","LU1551013425.SGD","SHOC","IE0001KFT4U8.USD","IE0034235303.USD","LU1934455194.USD","LU1629891620.HKD","LU0557290698.USD","LU2764263203.CNY","LU0861579265.USD","LU2357305700.SGD","LU0109391861.USD","IXN","LU0689472784.USD","BK4587","LU1852331112.SGD","HK0000320264.USD","SNVD.UK","LU0143551892.USD","BK4576","IE00B3M56506.USD","LU0417517546.SGD","BK4577","SG9999014567.USD","LU1400636657.SGD","LU2102340556.USD","LU0048584097.USD","TDIV","LU0784383803.USD","LU1228905540.USD","LU1935043023.USD","LU1992135399.USD","IE0009356076.USD","LU0912757837.SGD","LU2362540622.SGD","TTXU","LU1206713676.USD","LU0310800379.SGD","LU0061474705.USD","LU0345774391.USD","LU2279689827.SGD","IE00B64PRP62.GBP","LU2272731600.USD","SG9999018857.SGD","DFTX","LU2403377893.USD","PTIR","LU0879622024.SGD","ORCU","LU0251132253.USD","LU1823568750.SGD","IE000SO60NU8.SGD","IE00B1XK9C88.USD","LU1496350502.SGD","BK4503","SG9999003800.SGD","LU0211327993.USD","LU2089985449.USD","BK4543","LU0238689110.USD","ABFL","LU2087625088.SGD","LU1670711123.USD","LU0957791311.USD","LU3102509885.SGD","09388","LU0784384876.USD","LU1244550221.USD","LU0198837287.USD","LU1721428933.USD","BK4608","LU2047632596.USD","SOXX","LU1868836757.USD","OGIG","LU2108987350.USD","PLTL","LU0079474960.USD","LU1153585028.USD","LU1868836591.USD","IE00BN8TJ469.HKD","SHLD","LU1989764748.USD","LU0528227936.USD","2NVD.UK","ANV","IE00BK4W5M84.HKD","SG9999002224.SGD","USD","LU1429558221.USD","SNVDAmain","LU1861558580.USD","IE00B4YYXB79.USD","IE0034235188.USD","TRFK","LU1935043452.HKD","LU0048573561.USD","LU0314104364.USD","LU2362541513.USD","LU1983260115.SGD","LU1720051017.SGD","LU2236285917.USD","LU0689626769.HKD","LU2357627491.SGD","LU1221951129.SGD","LU2362541273.HKD","LU0708995401.HKD","LU0056508442.USD","LU0894485498.HKD","LU0211328371.USD","LU2458330169.SGD","SG9999017495.SGD","LU2506951875.HKD","LU1301847155.USD","09788","IE00BFXG0V08.USD","LU2361044949.HKD","LU0511384066.AUD","LU2360107168.USD","LU2125909593.SGD","LU2077746001.SGD","LU0708994859.HKD","SG9999015945.SGD","LU2720916845.USD","LU0289941410.SGD","LU1979441026.SGD","LU2505996681.GBP","LU2237957902.USD","LU2286300806.USD","BK4551","LU1633808545.USD","LU0898699433.AUD","NVDG","LU2265009873.SGD","NVDS.UK","LU1564329115.USD","BK4023","LU0472753341.HKD","LU1564329628.SGD","NVC","PLOO","FTEC","IE00BFXG1179.USD","LU2237443622.USD","HK0000819398.USD","IE000YTNTUN2.SGD","LU0274383776.USD","LU0823417737.USD","LU0942090050.USD","BK4605","LU0648001328.SGD","LU2491050154.USD","NVDD","LU0823434740.USD","IE000MB6IJN5.SGD","IE00BFSS8Q28.SGD","NVDY","LU1035773651.USD","SPTE","IE00BMPRXQ63.HKD","JGRO","LU2471134523.USD","IE00BSNM7G36.USD","LU0095938881.EUR","LU1712237335.SGD","BK4588","LU2294711713.HKD","ORAC","LU1935042991.SGD","LU1697837992.HKD","IE000KEQY171.SGD","LU0444973449.USD","LU0553294199.USD","LU1074936037.SGD","LU2360032135.SGD","LU2491050071.SGD","LU1839511570.USD","LU2298321311.HKD","LU2089283258.USD","LU0077335932.USD","PLTI","LU1064131342.USD","LU0096364046.USD","LU1861220033.SGD","LU1914381329.SGD","MSFT","LU0738911758.USD","PLTG","GAMR","LU1181866309.USD","LU2249611893.SGD","LU1489326972.SGD","LU0061474960.USD","LU2746668461.USD","IE000F7OJYX1.SGD","IE00BKDWB100.SGD","LU2462591277.SGD","LU1917777945.USD","LU1868836914.USD","LU0323239441.USD","IE000M9KFDE8.USD","3NVD.UK","LU1868837300.USD","HK0000914686.HKD","SMHX","LU2087621335.USD","LU2237443978.SGD","LU0965508806.USD","MSFY","BAH","PRVT","BK4527","IE0004086264.USD","LU1280957306.USD","LU0345770308.USD","LU0433182093.SGD","LU1242518931.SGD","SG9999015952.SGD","LU1989763005.USD","SMSFTmain","TYLG","LU1037948897.HKD","LU1069347547.HKD","BK4585","GB00BDT5M118.USD","IE00BMPRXN33.USD","LU0070302665.USD","LU1261432733.SGD","LU1400636491.USD","LU2347655156.SGD","LU2413666699.HKD","LU2506952170.USD","LU2148611432.USD","LU2750360997.AUD","LU1670711040.USD","LU0256863902.USD","BWIN","LU2420271590.USD","LU1267930490.SGD","LU2237443895.HKD","SG9999014906.USD","LU1645745479.HKD","LU2361045086.USD","IE00BFSS7M15.SGD","LU2065169927.USD","LU1046421795.USD","LU0889566641.SGD","CLSE","LU1582987324.SGD","NVD2.UK","PLTY","BK4547","IE00BK4W5L77.USD","LU0251142724.SGD","IE00BLSP4452.SGD","LU2065170008.USD","LU2404859667.USD","VGT","LU1228905037.USD","CHPX","LU2264538146.SGD","LU0308772762.SGD","IETC","LU0784385840.USD","LU2746668974.SGD","PLT","LU0053666078.USD","SG9999018865.SGD","LU0792757196.USD","LU1923623000.USD","LU2100268510.USD","MSFC","LU2456880835.USD","LU2471134879.HKD","LU0466842654.USD","LU2430703178.SGD","LU0787776722.HKD","LU2023251221.USD","IE00BKPKM429.USD","LU0106261372.USD","LU0097036916.USD","IE00BKVL7J92.USD","PLYY","NVDB","SG9999014898.SGD","LU2931357623.SGD","LU0724617625.USD","KKR","IE00BYQQ9H92.USD","LU2210149790.SGD","LU0323240290.USD","NULC","LU1244550494.USD","LU0158827948.USD","LU0187121727.USD","LU1582986433.USD","LU2237443465.HKD","LU1718418525.SGD","LU0310799852.SGD","NVDW","LU2290526834.HKD","BK4554","LU0823414478.USD","LU2275660780.HKD","LU0859254822.USD","LU2592432038.USD","BK4525","LU0690374615.EUR","LU0354030511.USD","LU2023250330.USD","XLK","LU1196500208.SGD","LU0757359954.USD","LU1366192091.USD","LU2404859741.USD","LFGY","HK0000914660.USD","IE00B3S45H60.SGD","LU0215105999.USD","SG9999011175.SGD","IE00B1BXHZ80.USD","LU0203202063.USD","LU1059921491.USD","LU1935042488.USD","MSFL","BK4516","IE00BJJMRY28.SGD","LU1861215975.USD","LU0795875086.SGD","LU2237443382.USD","ILDR","IE000BZT7R73.USD","IE00B894F039.SGD","LU1003077747.HKD","LU0965509283.SGD","LU1868837136.USD","IE00BBT3K403.USD","LU1035775433.USD","LU0208291251.USD","LU2326559502.SGD","LU1430594728.SGD","IE000W1ABFV2.USD","LU2471134952.CNY","SG9999014559.SGD","LU1935042215.USD","LU1235295455.SGD","IE00B19Z9Z06.USD","IGV","LU0871640123.AUD","IE00BWXC8680.SGD","LU1974910355.USD","IE0034235295.USD","LU1791807156.HKD","LU0949170772.SGD","LU1623119135.USD","NVD3.UK","LU2028103732.USD","LU1815336760.USD","SMH","LU0171293334.USD","LU0316494557.USD","LU0965509010.AUD","HK0000306685.HKD","LU1334329650.SGD","LU0868494617.USD","LU0795875169.SGD","LU2168564495.EUR","LU2357125470.USD","LU2764263039.SGD","IE0005OL40V9.USD","LU2506951792.HKD","LU2381873111.SGD","LU2552382215.SGD","PLTZ","GB00B4QBRK32.GBP","LU0174119429.USD","LU1732800096.USD","SNPE","SG9999015358.SGD","LU1206712785.SGD","IE00B775H168.HKD","LU0170899867.USD","LU2023250504.SGD","LU2125154935.USD","USXF","LU0128525929.USD","LU1066051498.USD","LU0011850046.USD","IE00BZ199S13.USD","BK4579","LU0210536198.USD","LU0106831901.USD","KBWP","LU2361044865.SGD","SG9999014914.USD","LU1582986359.USD","LU0345770993.USD","IE00BN29S564.USD","BK4598","LU0882574139.USD","LU0175139822.USD","LU0070217475.USD","LU0683600562.USD","IE0004091025.USD","LU2322448957.HKD","LU2543165471.USD","LBO","HK0000304805.HKD","NVDL","IE0003U64NQ7.SGD","IE00BQXX3D17.EUR","LU0476273544.USD","LU0823414551.USD","LU0158827781.USD","GPZ","LU1674673428.USD","IE0002270589.USD","LU1551013342.USD","LU2756315318.SGD","LU0980610538.SGD","LU2764262908.HKD","HK0000320223.HKD","LU0234570918.USD","IE00B19Z9505.USD","LU0320765489.SGD","HK0000304797.USD","AAUM","LU2083900584.USD","LU2168564065.EUR","LU2417539215.USD","LU0426412945.USD","LU1121112475.USD","LU2506951958.HKD","LU0276348264.USD","LU2250418816.HKD","LU2750360641.GBP","NVDO","LU1202635105.USD","IE00B19Z3B42.SGD","LU0068578508.USD","IE00B19Z3581.USD","LU1242518857.USD","LU2125909759.SGD","LU0345768153.USD","LU0072461881.USD","LU0149725797.USD","LU1803068623.USD","LU0006306889.USD","LU2133065610.SGD","LU0354030438.USD","SG9999015986.USD","IE00BJLML261.HKD","LU2092937148.SGD","SG9999014880.SGD","SG9999015341.SGD","LU1582987597.SGD","LU2125909247.SGD","LU1145028129.USD","LU1934455277.USD","IE00BDRTCR15.USD","SG9999004303.SGD","LU0347712357.USD","LU2097829019.USD","SGXZ31699556.SGD","IE00BMPRXR70.SGD","LU0426417589.USD","SG9999002232.USD","LU1670756490.USD","IE00BD6J9T35.USD","LU2271345857.HKD","IE00B7SZLL34.SGD","07788","LU0096362180.USD","LU0345768740.USD","LU2347655073.USD","SG9999015978.USD","LU1935043536.SGD","LU2242649171.HKD","LU0690374961.EUR","LU0820561909.HKD","CMAG","PLTR","AIFD","LU0353189680.USD","LU2213496289.HKD","LU2505996509.AUD","LU1880398471.USD","LU0251131958.USD","LU0889565833.HKD","LU0994945656.USD","LU1989772840.SGD","LU1066051225.USD","IE00BJTD4V19.USD","LU0640476718.USD","BK4534","SGXZ81514606.USD","IE00B19Z9P08.USD","LU1066053197.SGD","LU1506573853.SGD","LU0820561818.USD","LU2272731782.SGD","LU0964807845.USD","BK4529","LU0390134368.USD","LU0661504455.SGD","CNEQ","IE000Q6AESB8.SGD","LU0642271901.SGD","DIPS","LU2954938101.SGD","LU0320765059.SGD","LU1232071149.USD","LU1564329032.USD","LU1144417596.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667887","title":"First Marijuana, Then Peptides. Why Psychedelics are Wall Street's Next Big Trip.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667887?lang=en_us&edition=fundamental","pubTime":"2026-09-14 23:53","pubTimestamp":1789401180,"startTime":"0","endTime":"0","summary":"First marijuana, then peptides-and now psychedelics are getting a second look, as Definium Therapeutics advances the case for medical LSD.The drugmaker on Monday reported positive late-stage trial dat","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667648676","title":"Definium Therapeutics Inc : Leerink Partners Raises Target Price to $70 from $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2667648676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667648676?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:14","pubTimestamp":1789395280,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658276","title":"Definium Therapeutics Price Target Maintained with a $66.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658276","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658276?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:00","pubTimestamp":1789387200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667736663","title":"Definium Therapeutics Shares Gain After Reporting Positive Results in Anxiety Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667736663","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667736663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:54","pubTimestamp":1789386840,"startTime":"0","endTime":"0","summary":"Definium Therapeutics said it reported positive topline results from its second phase 3 study of DT120, an orally disintegrating tablet in adults with generalized anxiety disorder.This is its third positive phase 3 readout for DT120 ODT, following positive results in major depressive disorder announced in June and in generalized anxiety disorder announced in August.Shares were halted earlier in premarket trading and have resumed, gaining 18.7% and trading at $38.89 on Monday.The company said the latest study met the primary endpoint along with key secondary efficacy endpoints. This demonstrates a statistically-significant and clinically-meaningful improvement from baseline compared with a placebo, as measured by the change in Hamilton Anxiety Rating Scale total score at Week 12, it said.The drug was generally well-tolerated, with a safety profile consistent with prior clinical experience, the company said.\"Building on this momentum, we are advancing toward an NDA submission and look fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667813663","title":"Definium Therapeutics Shares Jump 20% Premarket After Co's Lsd-Based Drug Lowers Anxiety in Second Successful Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2667813663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667813663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:32","pubTimestamp":1789385576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4560TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":-0.0504},{"period":"1month","weight":-0.1803},{"period":"3month","weight":-0.1829},{"period":"6month","weight":1.0543},{"period":"1year","weight":2.7403},{"period":"ytd","weight":1.7431}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.2099},{"period":"1year","weight":0.1605},{"period":"ytd","weight":0.125}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.037703},{"month":5,"riseRate":0.5,"avgChangeRate":0.01554},{"month":6,"riseRate":0.5,"avgChangeRate":0.064762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.160554},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090843},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.158258},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction